dc.creatorMartinelli, Reinaldo
dc.creatorLopes, Antonio Alberto da Silva
dc.creatorOliveira, Moema M. M. G. de
dc.creatorRocha, Heonir
dc.creatorMartinelli, Reinaldo
dc.creatorLopes, Antonio Alberto da Silva
dc.creatorOliveira, Moema M. M. G. de
dc.creatorRocha, Heonir
dc.date.accessioned2013-10-31T17:55:33Z
dc.date.accessioned2022-10-07T18:36:12Z
dc.date.available2013-10-31T17:55:33Z
dc.date.available2022-10-07T18:36:12Z
dc.date.created2013-10-31T17:55:33Z
dc.date.issued1981
dc.identifier0066-4804
dc.identifierhttp://repositorio.ufba.br/ri/handle/ri/13416
dc.identifierv. 20, n. 6
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4011756
dc.description.abstractTwenty-one adult patients with urinary tract infections caused by penicillinresistant bacteria completed treatment with amoxicillin alone or amoxicillin plus clavulanic acid in a randomized double-blind clinical trial. Of the 13 patients treated with amoxicilhin plus clavulanic acid, the absence of bacteriuria within 7 days of therapy was observed in 85%, as compared with only 25% of the 8 patients receiving amoxicillin only. There were no significant side effects nor any clinical, biochemical, or hematological abnormalities related to either treatment. It was concluded that the combination of clavulanic acid and amoxicillin could be useful in the treatment of uncomplicated urinary tract infection caused by penicillinresistant bacteria.
dc.languageen
dc.publisherAntimicrobial Agents and Chemotherapy
dc.source10.1128/AAC.20.6.800
dc.titleAmoxicillin-Clavulanic Acid in Treatment of Urinary Tract Infection Due to Gram-Negative Bacteria Resistant to Penicillin
dc.typeArtigo de Periódico


Este ítem pertenece a la siguiente institución